)
Fulcrum Therapeutics (FULC) investor relations material
Fulcrum Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 24, 2026, to be held virtually for stockholders of record as of April 27, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class I directors for three-year terms expiring at the 2029 annual meeting: Sonja Banks, Alan Ezekowitz, and Colin Hill.
Non-binding advisory vote on executive compensation (say-on-pay).
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Provision for transaction of any other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting for all director nominees and for all proposals on the agenda.
- Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.FULC
Proxy filing1 May 2026 - Pociredir showed strong efficacy and safety, with $333M cash runway supporting operations into 2029.FULC
Q1 202628 Apr 2026 - Pociredir demonstrated strong efficacy and safety in SCD, supporting advancement to late-stage trials.FULC
Corporate presentation27 Apr 2026 - Pociredir achieved rapid, robust HbF increases and improved outcomes in sickle cell disease.FULC
44th Annual J.P. Morgan Healthcare Conference12 Apr 2026 - Pivotal study planned after strong PIONEER data, with focus on sickle cell and U.S. launch.FULC
Leerink Global Healthcare Conference 202626 Mar 2026 - Pociredir achieved strong HbF induction and safety in SCD, advancing toward pivotal trials.FULC
Corporate presentation13 Mar 2026 - Strong HbF induction, clinical benefit, and cash runway support pivotal trial in 2026.FULC
Q4 202524 Feb 2026 - 20 mg dose led to strong HbF increases, improved anemia, and no serious safety issues.FULC
Status Update3 Feb 2026 - $80M Sanofi deal drives Q2 profit; cash runway extends into 2027, key data due by October.FULC
Q2 20242 Feb 2026
Next Fulcrum Therapeutics earnings date
Next Fulcrum Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)